Category: Workers Comp

499 posts found

Federal Opioid Reform Bill Signed into Law

With an enormous range of initiatives to prevent and treat opioid use disorder, the bill has officially been signed by the President.

Medmonitor

FDA Approves New Dosage for Opioid Dependence Therapy

Cassipa (buprenorphine and naloxone) sublingual film delivers a new dosage for the treatment of opioid dependence.

This Month's Must Read

Dr. Silvia Sacalis Discusses Polypharmacy with WC Magazine

Healthesystems’ VP of Clinical Services explains how too many drugs in a claim can cause health concerns, and what can be done to prevent them.

Legislation & Policy

FDA Reassesses Opioid Policies

The FDA is working to create new opioid prescribing practices and guidelines, while also shifting drug development priorities for pain medications.

Clinical Insights

CWCI Releases Polypharmacy Report

According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

Opioid Developments

Massachusetts Study Links Occupation to Opioid Overdose Deaths

On average, construction workers are six times more likely to die from an opioid overdose death, more than any other occupation.

Healthe Developments

Dr. Robert Goldberg Comments on DEA Opioid Manufacturing Quotas

Healthesystems’ Chief Medical Officer spoke with WorkCompCentral regarding DEA plans to reduce opioid manufacturing.

Medmonitor

FDA Accepts New Drug Application for Opioid NKTR-181

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

This Month's Must Read

Sandy Shtab Discusses the Need to Modernize Regulation with WorkCompWire

Healthesystems’ AVP of Advocacy & Compliance explains how regulation has been unable to keep pace with healthcare innovation & technology.

Legislation & Policy

PTSD Legislation Continues to Grow

More states cover PTSD without physical injuries for first responders, and 24 states allow PTSD patients to use medical marijuana.

Clinical Insights

New Developments in Migraine Medications

A new wave of drugs that suppress CGRP proteins to reduce migraines could be on the horizon.

Opioid Developments

FDA Proposes New Clinical Endpoints for Development of Opioid-Use Disorder Drugs

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

Healthe Developments

Healthe Clinical Leaders in the News

Our Chief Medical Officer and VP of Clinical Services comment on matters such as the use of anticonvulsants to treat pain and opioid prescriptions for inpatients.

Medmonitor

New Opioid in Development May Offer Reduced Risk Profile

Phase 2/3 clinical trial results for Korsuva demonstrate pain relief with fewer side effects.

This Month's Must Read

Mark of the Millennial: Managed Care for a New Generation

Millennials are more diverse and more open to alternative therapies, medical marijuana, healthcare technology, and dialogue surrounding psychosocial concerns.

Prev 1 2 3 4 5 … 29 30 31 32 33 34 Next